D.A. Davidson & CO. Has $12.29 Million Position in CVS Health Corporation (NYSE:CVS)

D.A. Davidson & CO. trimmed its position in CVS Health Corporation (NYSE:CVS - Free Report) by 3.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 181,358 shares of the pharmacy operator's stock after selling 6,467 shares during the quarter. D.A. Davidson & CO.'s holdings in CVS Health were worth $12,287,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Hopwood Financial Services Inc. bought a new position in CVS Health during the fourth quarter worth about $29,000. McIlrath & Eck LLC grew its position in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. MV Capital Management Inc. increased its holdings in shares of CVS Health by 63.9% during the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 289 shares during the period. Dunhill Financial LLC boosted its stake in shares of CVS Health by 147.2% in the first quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock valued at $51,000 after buying an additional 446 shares during the period. Finally, Atwood & Palmer Inc. grew its position in CVS Health by 228.0% during the first quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator's stock worth $56,000 after buying an additional 570 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on CVS shares. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Royal Bank Of Canada upped their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Robert W. Baird raised their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Jefferies Financial Group upped their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a report on Monday. Finally, Truist Financial lifted their price objective on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Trading Up 1.2%

Shares of CVS stock opened at $67.38 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $85.23 billion, a P/E ratio of 16.08, a P/E/G ratio of 0.95 and a beta of 0.57. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The stock's fifty day simple moving average is $65.06 and its 200 day simple moving average is $61.31.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.31 earnings per share. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Insider Transactions at CVS Health

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were bought at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.